tiprankstipranks
Trending News
More News >
AstraZeneca announces Calquence with venetoclax recommended for approval in EU
PremiumThe FlyAstraZeneca announces Calquence with venetoclax recommended for approval in EU
1d ago
AstraZeneca to discontinue CAPItello-280 Phase III trial on Truqap
Premium
The Fly
AstraZeneca to discontinue CAPItello-280 Phase III trial on Truqap
1d ago
AstraZeneca maintain 2025 sales guidance despite potential tariffs, Reuters say
Premium
The Fly
AstraZeneca maintain 2025 sales guidance despite potential tariffs, Reuters say
1d ago
Eli Lilly, Pfizer, Amgen – Trump’s 25% Pharma Tariffs Could Drain $51B Annually
PremiumMarket NewsEli Lilly, Pfizer, Amgen – Trump’s 25% Pharma Tariffs Could Drain $51B Annually
2d ago
AstraZeneca price target lowered to $79 from $86.60 at HSBC
Premium
The Fly
AstraZeneca price target lowered to $79 from $86.60 at HSBC
2d ago
AZN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AZN Upcoming Earnings Report: What to Expect?
3d ago
BTIG says AstraZeneca deal demonstrates value of Tempus AI data AI business
PremiumThe FlyBTIG says AstraZeneca deal demonstrates value of Tempus AI data AI business
7d ago
Tempus AI announces oncology collaboration with AstraZeneca, Pathos AI
Premium
The Fly
Tempus AI announces oncology collaboration with AstraZeneca, Pathos AI
7d ago
Promising Trial Results and Physician Enthusiasm Bolster AstraZeneca’s Stock Outlook
Premium
Ratings
Promising Trial Results and Physician Enthusiasm Bolster AstraZeneca’s Stock Outlook
7d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100